Skip to main content

Together we are beating cancer

Donate now

Children and young people's cancers

Children develop different types of cancers than adults, with around 1,900 children under the age of 14 diagnosed each year. The most common types of childhood cancer are acute leukaemia and cancers of the brain and spinal cord. Thanks to research into new treatments, 8 in 10 children diagnosed with cancer will live for at least five years.
Showing 12 out of 199 results
scientists in a lab

Cancer Research UK and LifeArc are investing £28m in funding and resources as part of a pioneering international initiative dedicated to developing new medicines exclusively for children’s and young people’s cancers. Cancer Research UK and LifeArc are investing £28m in funding and resources as part of a pioneering international initiative dedicated to developing new medicines exclusively for children’s and young people’s cancers.

by Sophie Wedekind | News | 5 September 2024

5 September 2024

Abdullah, Aleesha-Marie and Faye, who all took part in clinical trials funded by Cancer Research UK

Clinical trials are how we bring better cancer treatments to children and young people. For Childhood Cancer Awareness Month, we asked parents what they're actually like. Clinical trials are how we bring better cancer treatments to children and young people. For Childhood Cancer Awareness Month, we asked parents what they're actually like.

by Tom Bourton, Tim Gunn | Personal stories | 3 September 2024

3 September 2024

Microscopy image of Hodgkin's lymphoma

Since the 1970s, our work has helped double children's cancer survival in the UK. Here are some of our biggest achievements from the last 50 years that wouldn't have been possible without the support of our partners and supporters. Since the 1970s, our work has helped double children's cancer survival in the UK. Here are some of our biggest achievements from the last 50 years that wouldn't have been possible without the support of our partners and supporters.

by Cancer Research UK | In depth | 3 September 2024

3 September 2024

Two cancer researchers looking at a cell image on screen

For Childhood Cancer Awareness Month, we're highlighting some our most important research into children's and young peoples' cancers over the past year. For Childhood Cancer Awareness Month, we're highlighting some our most important research into children's and young peoples' cancers over the past year.

by Momoko Bowles | Analysis | 1 September 2024

1 September 2024

Brain scans

Stand Up To Cancer are giving two international teams each a further £3.75m to reduce the side effects of radiotherapy and make immunotherapies work for more young patients. Stand Up To Cancer are giving two international teams each a further £3.75m to reduce the side effects of radiotherapy and make immunotherapies work for more young patients.

by Tim Gunn | Analysis | 7 August 2024

7 August 2024

Cancer Research UK scientists in the lab

NHS England will offer the newly-approved dabrafenib plus trametinib combination to children and young people whose gliomas are being driven by a specific genetic mutation. NHS England will offer the newly-approved dabrafenib plus trametinib combination to children and young people whose gliomas are being driven by a specific genetic mutation.

by Tim Gunn | News | 13 June 2024

13 June 2024

Issy, Jake and Joram, who shared their stories with us for Teenage and Young Adult Cancer Awareness Month.

April is Teenage and Young Adult Cancer Awareness Month. Three teenagers who were diagnosed with cancer share their experiences and advice. April is Teenage and Young Adult Cancer Awareness Month. Three teenagers who were diagnosed with cancer share their experiences and advice.

by Tom Bourton, Tim Gunn | Personal stories | 2 April 2024

2 April 2024

A Cancer Research UK-funded researcher in the lab.

We helped fund a trial into neuroblastoma treatment that has improved how doctors treat the disease when other options aren't working. It's an important step forward in treating these relapsed and refractory tumours, which have some of the lowest survival rates for any childhood cancer.   We helped fund a trial into neuroblastoma treatment that has improved how doctors treat the disease when other options aren't working. It's an important step forward in treating these relapsed and refractory tumours, which have some of the lowest survival rates for any childhood cancer.  

by Tim Gunn | News | 10 January 2024

10 January 2024

Bacterial microbiome mapping. Orange lines making connections and overlapping each other.

The microbiome is made up of trillions of microbes, including bacteria, fungi and even viruses. A research group believes this bustling community could be the key for preventing childhood acute lymphoblastic leukaemia. The microbiome is made up of trillions of microbes, including bacteria, fungi and even viruses. A research group believes this bustling community could be the key for preventing childhood acute lymphoblastic leukaemia.

by Sophie Wedekind | Analysis | 3 January 2024

3 January 2024